TITLE

A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted?

AUTHOR(S)
Evans, T. W.; Gatzoulis, M. A.; Gibbs, J. S. R.
PUB. DATE
June 2002
SOURCE
Thorax;Jun2002, Vol. 57 Issue 6, p471
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
In pulmonary hypertension (PH) resting mean pulmonary artery pressure exceeds 25 mm Hg at rest or 30 mm Hg during exercise. PH may complicate many different clinical disease processes or may develop as a primary phenomenon (PPH). Post mortem studies estimate the prevalence to be 1300 per million. The incidence of PPH in Europe and the USA is 1-2 cases per million population per year, rising to as high as 25-50 per million per year in patients using certain appetite suppressants. The mean age at diagnosis is 36 years with a female preponderance. There is no ethnic predisposition but familial PPH accounts for roughly 10% of cases.
ACCESSION #
12915577

 

Related Articles

  • Development of Pulmonary Aneurysm in Primary Pulmonary Hypertension: A Case Report. Nienaber, Christoph A.; Spielmann, Rolf P.; Montz, Ricardo; Bleifeld, Walter; Mathey, Detlef G. // Angiology;Apr1986, Vol. 37 Issue 4, p319 

    Selected cases of severe primary pulmonary arterial hypertension and associated pulmonary vascular disease have been related to the oral ingestion of aminorex fumarate, an anorexigen obviously responsible for an epidemic of primary pulmonary hypertension in Western Europe between 1967 and 1970....

  • Conventional and targeted medical therapies. Barst, Robyn J.; Stewart, Duncan // Cardiology in the Young;May2009, Vol. 19 Issue S1, p28 

    The article offers information on the conventional medical therapy to patient with pulmonary hypertension, a progressive disease which is also defined as pulmonary vascular obstructive disease. It notes that patient with pulmonary arterial hypertension is advised to maintain physical activities...

  • Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis. Elliott, C. G.; Palevsky, H. I. // Thorax;Jun2004, Vol. 59 Issue 6, p536 

    Pulmonary hypertension frequently complicates mitral stenosis. Increased pulmonary artery pressure result from raised left atrial pressure, pulmonary arteriolar constriction, and obliterative changes in the pulmonary vascular bed, and usually responds to surgical relief of mitral stenosis....

  • PRIMARY PULMONARY HYPERTENSION: FAMILIAL INCIDENCE. Boiteau, G. M.; Libanoff, A. J. // Angiology;May1963, Vol. 14 Issue 5, p260 

    The rare incidence of familial primary pulmonary hypertension (PPH) was presented in the case of two sister's. A brief review of the literature was presented. The congenital origin of PPH was discussed and related probably to the persistence of the fetal pulmonary circulation, or to the...

  • Giant Pulmonary Artery Aneurysm in a Patient with Rheumatic Mitral Stenosis. Singh, Vikas; Khare, Rashi; Chandra, Sharad; Dwivedi, Sudhanshu Kumar // Heart Views;Jul-Sep2014, Vol. 15 Issue 3, p89 

    Pulmonary artery (PA) aneurysm is a rare condition, frequently associated with pulmonary hypertension. However, the evolution and treatment of this pathology is still not clear. We report a case of a 45-year-old female patient with giant PA aneurysm associated with rheumatic mitral stenosis and...

  • Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Gonzalez-Lopez, L.; Cardona-Mu�oz, E. G.; Celis, A.; la Torre, I. Garc�a-de; Orozco-Barocio, G.; Salazar-Paramo, M.; Garcia-Gonzalez, C.; Garcia-Gonzalez, A.; Sanchez-Ortiz, A.; Trujillo-Hernandez, B.; Gamez-Nava, J. I. // Lupus;2004, Vol. 13 Issue 2, p105 

    The aim of this study was to compare the efficacy of intravenous cyclophosphamide (IVCYC) versus oral enalapril in mild or moderate pulmonary hypertension (PH) in systemic lupus erythematosus (SLE). Thirty-four patients with SLEwho had systolic pulmonary artery pressure (SPAP) > 30mmHg by...

  • Editorial [Chronic Thromboembolic Pulmonary Hypertension-Therapeutic Options]. Surani, Salim // Current Respiratory Medicine Reviews;2006, Vol. 2 Issue 4, p355 

    The pulmonary circulation is normally a low-pressure, low resistance circuit due to its large cross-sectional area and high capacitance. Pulmonary hypertension is defined as a mean pulmonary arterial pressure >25 mm Hg at rest or 30 mm Hg at exercise at catheterization. Chronic thromboembolic...

  • Paradoxical Effect of Prostacyclin Infusion in a Patient with Primary Pulmonary Hypertension. Younger, Jared R.; Lui, Charles Y. // Angiology;May/Jun2004, Vol. 55 Issue 3, p341 

    Prostacyclin treatment successfully delays the need for lung transplantation in many patients with progressive primary pulmonary hypertension by vasodilating pulmonary arteries. However, the treatment of pulmonary hypertension with prostacyclin may cause a paradoxical increase in pulmonary...

  • Prolactin and Its 16-kDa N-Terminal Fragment. Albrecht, Uta Hönicke Steffen; Schrötter, Hagen; Krug, Sabine; Kolditz, Martin; Kuhlisch, Eberhard; Höffken, Dipl-Math Gert; Halank, Michael // Texas Heart Institute Journal;2012, Vol. 39 Issue 1, p44 

    We sought to determine whether patients with precapillary pulmonary hypertension show elevated serum levels of prolactin (PRL) and its 16-kDa N-terminal fragment (16-kDa PRL) and whether there is any correlation to measures of prognosis. Twenty-eight patients with idiopathic pulmonary artery...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics